Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zimmer slides on Q3 profit slide, narrowed guidance
Mass Device
Thursday, October 24, 2013 - 10:24am
tags:
Zimmer, earnings, devices
Bristol-Myers Squibb - There Is Life After Plavix
Seeking Alpha
Thursday, October 24, 2013 - 10:19am
tags:
Plavix, Bristol-Myers Squibb, JNJ, PFE
Mead Johnson profit rises as volumes grow in China, Hong Kong
Reuters
Thursday, October 24, 2013 - 10:18am
tags:
earnings, China, Hong Kong, Mead Johnson
Boston Scientific Will Cut 1,100-1,500 Jobs Through 2015
Bloomberg
Thursday, October 24, 2013 - 10:13am
tags:
layoffs, devices, Boston Scientific
Cubist Pharmaceuticals Completes Acquisition of Optimer Pharmaceuticals
Yahoo
Thursday, October 24, 2013 - 10:11am
tags:
Optimer Pharmaceuticals, M&A, Cubist Pharmaceuticals
Amarin Could Still Turn Profitable
Seeking Alpha
Thursday, October 24, 2013 - 10:03am
tags:
Amarin, Vascepa, GSK, Teva
Celgene's New Multiple Myeloma Drug Is Beating Amgen
TheStreet.com
Thursday, October 24, 2013 - 9:59am
tags:
Celgene, Multiple Myeloma, Amgen, Kyprolis, Pomalyst
Celgene profit lower; raises full-year forecast
Yahoo/Reuters
Thursday, October 24, 2013 - 9:56am
tags:
Celgene, earnings
McKesson Agrees to Buy Celesio for $5.4 Billion
Bloomberg
Thursday, October 24, 2013 - 8:49am
tags:
Celesio, McKesson, M&A
Rigel to drop skin disease drug after trial failure
Yahoo/Reuters
Thursday, October 24, 2013 - 8:47am
tags:
Rigel Pharmaceuticals, discoid lupus, R333
2 Chinese Pharma Micro Caps To Look At Closely
Seeking Alpha
Thursday, October 24, 2013 - 8:46am
tags:
China, China Pharma Holdings, Biostar Pharmaceuticals
4 Ways AstraZeneca Will Continue To Lead The Biotechnology Sector
Motley Fool
Thursday, October 24, 2013 - 8:45am
tags:
AstraZeneca
Alexion Reports Third Quarter 2013 Results
Yahoo
Thursday, October 24, 2013 - 8:41am
tags:
Alexion, earnings
Amarin slashes staff by half after FDA panel rejection
Fierce Pharma
Wednesday, October 23, 2013 - 6:33pm
tags:
Amarin, layoffs, FDA, Vascepa
Ex-Bristol-Myers executive gets 1 yr in prison for insider trading
Yahoo/Reuters
Wednesday, October 23, 2013 - 6:32pm
tags:
insider trading, Bristol-Myers Squibb
Johnson & Johnson's Hidden Source Of Value
Seeking Alpha
Wednesday, October 23, 2013 - 6:31pm
tags:
JNJ
Big Pharma Fights Off the Dow's Drop
Motley Fool
Wednesday, October 23, 2013 - 5:01pm
tags:
Merck, Pfizer, MK-5172, MK-8742
3 Catalysts Biocryst Investors Need to Watch
Motley Fool
Wednesday, October 23, 2013 - 4:05pm
tags:
peremivir, Biocryst, BCX4161
Should You Be Excited About This Biotech's Earnings?
Motley Fool
Wednesday, October 23, 2013 - 4:04pm
tags:
Anika, earnings
Biotech volatility can mean danger or opportunity
Marketwatch
Wednesday, October 23, 2013 - 2:40pm
tags:
biotech, EXACT Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.